ArticleJournal of ultrasound2026
Enhancing conventional biopsies: ultrasound-guided percutaneous bone marrow biopsy and aspiration.
Article in Journal of ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the efficacy of ultrasound (US)-guided bone marrow biopsy technique.
methodsThe study retrospectively analyzed patients who underwent percutaneous bone marrow core biopsy and aspiration at a single institution from January 2017 to June 2024. Success metrics included lack of patient grievances, precision of sample acquisition, and technical procedural success.
resultsA sample population of 254 was composed of 150 males (median age of 63 years) and 104 females (median age of 63 years). The median (range) BMI was 27.08 (15.31-50.17) for males and 28.79 (17.17-54) for females. The technique achieved 100% accuracy rate with no procedure failures or adverse events reported. Samples collected were viable for pathology assessment. Procedure times ranged from 5 to 30 min. The biopsy was used in various diagnosis of histopathological disease processes. There were no reported dry taps on aspiration.
conclusionUS-guided percutaneous bone marrow biopsy and aspiration emerges as a promising technique, offering numerous advantages over traditional palpated landmark, fluoroscopic and CT-guided approaches. With its ability to provide real-time guidance, avoidance of ionizing radiation, and comprehensive evaluation of adjacent soft tissues and neurovascular structures, US-guided bone biopsy holds significant promise as an alternative to earlier methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.